11-Keto-β-Boswellic Acid Inhibits Lymphocyte (CD3) Infiltration Into Pancreatic Islets of Young None Obese Diabetic (NOD) Mice

Abstract

11-Keto-β-Boswellic acid (KBA) has been shown to prevent infiltration of lymphocytes into pancreatic islets and appearance of peri-insular apoptotic cells in an animal model of autoimmune diabetes caused by injection of Multiple Low Doses of Streptozotocin (MLD-STZ), which is a chemical compound belonging to the class of nitrososureas. The aim of this work was to study whether or not KBA can also prevent/attenuate infiltration of lymphocytes into pancreatic islets and appearance of peri-insular apoptotic cells in an animal model of autoimmune diabetes caused by genetic dysfunction resembling human type 1 diabetes in several important features. Four weeks old female NOD mice received daily i.p. injections of 7.5 mg/kg of KBA over a period of 3 weeks. Compared to 4 weeks old animals there was significant infiltration of lymphocytes (CD3) into pancreatic islets and appearance of peri-insular apoptotic cells in the period between 4 and 7 weeks. During this time plasma glucose dropped significantly and body weight did not increase. As far as pro-inflammatory cytokines are concerned, except a small increase of IFN-γ, there was no change in the blood. In mice that had been treated with KBA between 4 and 7 weeks after birth no significant infiltration of lymphocytes into pancreatic islets and appearance of peri-insular apoptotic cells was observed, when compared to 4 weeks old mice. Moreover, there was no drop of blood glucose and the animals gained body weight. It is concluded that – similar to the model of MLD-STZ-diabetes – also in the NOD mouse model KBA is able to attenuate or even prevent development of insulitis, suggesting that KBA protects islets from autoimmune reaction regardless whether the signal is provided by a chemical compound or by genetic dysfunction. Whether this also holds for human type 1 diabetes remains to be established.

Key words

boswellic acids - NOD mice - prevention - insulitis - histochemistry - cytokines

• References

• 1 Ammon HPT. Boswellic acids in chronic inflammatory diseases. Planta Med 2006; 72: 1100-1116
• 2 Ammon HPT. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomed 2010; 17: 862-867
• 3 Shehata AM, Quintanilla-Fend L, Bettio S, Jauch J, Scior T, Scherbaum WA, Ammon HPT. 11-Keto-β-boswellic acids prevent development of autoimmune reactions, insulitis and reduce hyperglycemia during induction of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice. Horm Metab Res 2015; 47: 463-469
• 4 Shehata AM, Quintanilla-Fend L, Bettio S, Singh GB, Ammon HPT. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE). Phytomed 2011; 18: 1037-1044
• 5 McEvoy RC, Andersson J, Sandler S, Hellerström C. Multiple low-dose streptozotocin – induced diabetes. Evidence for stimulation of a cytotoxic immune response against an insulin-producing cell line. J Clin Invest 1984; 74: 715-722
• 6 Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr Protoc Immunol 2001; Chapter 15 Unit 15-19
• 7 Castano L, Eisenbarth GS. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990; 8: 647-679
• 8 Lampeter EF, Signore A, Gale EA, Pozzilli P. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 703-708
• 9 Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: As good as it gets?. Nat Med 1999; 5: 601-604
• 10 Lenzen S. The mechanism of alloxan- and streptozotocin – induced diabetes. Diabetologia 2008; 51: 216-226
• 11 Pearson JA, Wong FS, Wen L. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun 2016; 66: 76-88
• 12 Kunder S, Calzada-Wack J, Holzwimmer G, Müller J, Kloss C, Howatt W, Schmidt J, Höfler H, Warren M, Quintanilla-Martinez L. A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: Analysis of mouse specific and human antibodies cross-reactive with murine tissue. Toxicol Pathol 2007; 35: 366-375
• 13 Jauch J, Gergmann J. An efficient method for the larger scale preparation of 3-O-acetyl-11-oxo-β-boswellic acid and other boswellic acids. Eur J Org Chem 2003; 4752-4756
• 14 Scior Th, Verhoff M, Gutierrez-Aztatzi J, Ammon HPT, Laufer S, Werz O. Interference of boswellic acids with the ligand binding domain of the glucocorticoid receptor. J Chem Inf Mod 2014; 54: 978-986
• 15 Nishida M, Sasaki T, Terada H, Kawada J. A sigmoidal relationship between liver stearoyl CoA desaturase activity and serum hormone concentrations caused by streptozotocin and ist antagonists. Experientia 1988; 44: 756-758
• 16 Yamamura K, Miyazaki T, Uni M, Toyonaga T, Miazaki J. Non-obese diabetic transgenic mouse. Springer Semin Immunopathol 1992; 14: 115-125
• 17 Debussche X, Lormeau B, Boitrad C, Toublanc M, Assan R. Course of pancreatic beta cell destruction in prediabetic NOD mice: Histomorphometric evaluation. Diabete Metab 1994; 20: 282-290
• 18 Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 1998; 139: 1115-1124
• 19 Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221-229
• 20 Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291-297
• 21 Rabinovitsch A. An update on cytokines in the pathogenesis of insulin –dependent diabetes mellitus. Diabetes Metab Rev 1998; 14: 129-151
• 22 Schrott E, Laufer S, Lämmerhofer M, Ammon HPT. Extract from gum resin of Boswellia serrata decreases IA₂-antibody in a patient with “Late onset Autoimmune Diabetes of the Adult” (LADA). Phytomed 2014; 21: 786